Skip to main content

Table 4 Quality assessment according to AHFMR 2004 (N = 1)

From: Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate

Criteria

Assessment*

Remarks

Altschuler & Somkin 2005 [19] (Score = 0.80**)

Research question(s)/Objective(s)

Yes

Described clearly and evident throughout the text

Study design

Partially

Not explicitly named; inconsistencies in subsequent data collection not evident

Study context

Yes

Setting is described

(Theoretical) frame of reference

Partially

Study objective does not completely follow the knowledge that is depicted in the introduction

Sampling

Partially

Described and reproducible; random sampling was performed until theoretical data saturation was reached; consent of women was obtained before the interviews began. Duration of study not mentioned.

Data collection

Yes

Reproducible

Data analysis

Yes

Categories, codes, and memos described; categories listed explicitly

Reliability

Yes

Second author verified formation of categories/assignment of codes by the first author; if there were discrepancies in the codes, they went back to the original material and found consensus

Conclusions

Yes

Results discussed; results of other studies are drawn upon as comparison

Reflexion

Partially

Possible influence of financial compensation were not reflected; recall bias listed as possible weakness of the study

  1. *Possible categories: yes, partially, no, not applicable
  2. ** Ascertainment according to AHFMR 2004 (p. 20) = ((number "yes" * 2) + (number "partially" * 1))/20